Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)

NCT06438640 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1881

Last updated 2026-03-12

No results posted yet for this study

Summary

The objective of this study is to assess the implementation process for and the effectiveness of a quality improvement (QI) strategy to increase shared decision-making around anesthesia options for hip fracture surgery at 6 US hospitals. The QI strategy is to be facilitated by a clinician-administered 1-page bedside conversation aid designed to improve the quality of physician-patient communication, paired with brief clinician training. The evaluation will occur via a stepped wedge, cluster randomized trial to be carried out over a period of 34 months.

Conditions

  • Hip Fractures
  • Femoral Neck Fractures
  • Intertrochanteric Fractures
  • Subtrochanteric Fractures

Interventions

BEHAVIORAL

My Anesthesia Choice-HF Model

Brief clinician training on shared decision making, paired with provision of a 1-page tabular format conversation aid listing answers to frequently asked questions regarding common anesthesia options for hip fracture surgery (spinal anesthesia; general anesthesia)

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER
  • Henry Ford Health System

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • Dartmouth College

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Mark Neuman, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-15
Primary Completion
2027-06-15
Completion
2028-06-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06438640 on ClinicalTrials.gov